Evaluation of Serum Prostatic Specific Antigen (PSA) After Cyproterone Compound Treatment Compared With Oral Contraceptives Pill in Hirsute Polycystic Ovary Syndrome Patients

• Status: Unknown status
• Trial end date: 2010-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to evaluate the effect of oral contraceptive on the serum free prostatic specific antigen (PSA)in women with polycystic ovary syndrome(PCOD)compared with cyproterone compound.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Shahid Beheshti University
• Treatments: Contraceptive Agents; Contraceptives, Oral; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate

Criteria

Inclusion Criteria:

• PCOS patients

Exclusion Criteria:

• Women who received hormone therapy during the last 3 months,

• On a diet

• Herbal treatment

• Hyperprolactinemia

• Thyroid disorders

• Ovarian tumors

• Cushing disease.